TRIM49D2 (Gene)

Entrez:729384

Description:tripartite motif containing 49D2

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response; protein ubiquitination; and regulation of gene expression. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TRIM49D2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TRIM49D2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TRIM49D2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TRIM49D2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TRIM49D2.

Results found

Linked to

	Label	Description
	GSE190937 AHCY MAT2A knockout Rael 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE190937 AHCY MAT2A knockout Rael 4 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 9 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 2 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115395 enzalutamide LNCaP 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 11 V 4 CISPLATIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE168401 harmine U2OS 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 9 V 1 SULFORAPHANE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE102467 3 V 0 PAZOPANIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 2 V 1 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE190937 AHCY MAT2A knockout Rael 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE190937 AHCY MAT2A knockout Rael 4 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE48812 sulforaphane 9 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE48812 sulforaphane 2 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE115395 enzalutamide LNCaP 2 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE216043 11 V 4 CISPLATIN HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE168401 harmine U2OS 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE48812 9 V 1 SULFORAPHANE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE102467 3 V 0 PAZOPANIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE225901 2 V 1 DEXAMETHASONE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.